Lymph node ratio as a tool to stratify patients with N1b papillary thyroid cancer

被引:1
作者
Luo, Ziyu [1 ,2 ]
Hei, Hu [1 ,2 ]
Qin, Jianwu [1 ,2 ]
Zheng, Chen [1 ,2 ]
Gong, Wenbo [1 ,2 ]
Zhou, Bin [1 ,2 ]
机构
[1] Zhengzhou Univ, Affiliated Canc Hosp, Dept Thyroid & Neck, Zhengzhou 450008, Peoples R China
[2] Henan Canc Hosp, Zhengzhou 450008, Peoples R China
关键词
Papillary thyroid cancer; Lymph node ratio; Disease-specific mortality; Overall survival; SEER; SURVIVAL; IMPACT;
D O I
10.1007/s00423-023-03033-w
中图分类号
R61 [外科手术学];
学科分类号
摘要
BackgroundThe prognostic significance of lymph node ratio (LNR) in N1b papillary thyroid cancer is unclear. Therefore, the impact of LNR on disease-specific mortality (DSM) and overall survival (OS) in patients with N1b papillary thyroid cancer (PTC) needs to be defined.MethodsWe used the Surveillance, Epidemiology, and End Results (SEER) database of patients who had undergone thyroidectomy and lymph node dissection. Factors associated with DSM and OS were analyzed and identified using univariate and multivariate Cox proportional risk models. X-tile software was used to find the best cutoff value of LNR. Kaplan-Meier estimates for DSM were plotted for LNR and were compared with the log-rank test. The ROC curve evaluated the validity of the model.ResultsA total of 3223 patients with N1b PTC were identified in the SEER database between 1975 and 2019. The best cutoff value for LNR was 0.6. The multivariate Cox proportional risk model showed that age, race, T3/T4 classification, distant metastasis, extent of surgery, number of metastatic lymph nodes, and LNR > 0.6 were independent risk factors for DSM (all p < 0.05). Age, sex, T4 classification, distant metastasis, extent of surgery, and LNR > 0.6 were independent risk factors for OS (all p < 0.05). The Kaplan-Meier method plotted a cumulative risk curve and showed that patients with LNR > 0.6 had a significantly higher risk of DSM than patients with LNR & LE; 0.6 (p = 0.002).ConclusionLNR was a powerful predictor of DSM and OS in N1b PTC patients. LNR could be a useful tool for the stratification of PTC patients with lateral neck metastases.
引用
收藏
页数:9
相关论文
共 50 条
  • [31] Clinical Outcomes of N1b Papillary Thyroid Cancer Patients Treated with Two Different Doses of Radioiodine Ablation Therapy
    Jin, Meihua
    Ahn, Jonghwa
    Lee, Yu-Mi
    Sung, Tae-Yon
    Kim, Won Gu
    Kim, Tae Yong
    Ryu, Jin-Sook
    Kim, Won
    Shong, Young Kee
    Jeon, Min Ji
    ENDOCRINOLOGY AND METABOLISM, 2020, 35 (03) : 602 - 609
  • [32] Lymph node characteristics of 6279 N1 differentiated thyroid cancer patients
    Sui, C.
    He, Q.
    Du, R.
    Zhang, D.
    Li, F.
    Dionigi, G.
    Liang, N.
    Sun, H.
    ENDOCRINE CONNECTIONS, 2020, 9 (03): : 201 - 210
  • [33] UNFAVORABLE RESPONSES TO RADIOIODINE THERAPY IN N1B PAPILLARY THYROID CANCER: A PROPENSITY SCORE MATCHING STUDY
    Liu, Yan-Qing
    Li, Hui
    Liu, Jie-Rui
    Lin, Yan-Song
    ENDOCRINE PRACTICE, 2019, 25 (12) : 1286 - 1294
  • [34] Association of Lymph Node Density With Survival of Patients With Papillary Thyroid Cancer
    Amit, Moran
    Tam, Samantha
    Boonsripitayanon, Mongkol
    Cabanillas, Maria E.
    Busaidy, Naifa L.
    Grubbs, Elizabeth Gardner
    Lai, Stephen Y.
    Gross, Neil D.
    Sturgis, Erich M.
    Zafereo, Mark E.
    JAMA OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2018, 144 (02) : 108 - 114
  • [35] Number of Metastatic Lymph Nodes and Ratio of Metastatic Lymph Nodes to Total Number of Retrieved Lymph Nodes Are Risk Factors for Recurrence in Patients With Clinically Node Negative Papillary Thyroid Carcinoma
    Zheng, Chuan-Ming
    Ji, Yong Bae
    Song, Chang Myeon
    Ge, Ming-Hua
    Tae, Kyung
    CLINICAL AND EXPERIMENTAL OTORHINOLARYNGOLOGY, 2018, 11 (01) : 58 - 64
  • [36] Metastatic Lymph Node Ratio for Predicting Recurrence in Medullary Thyroid Cancer
    Kim, Jinyoung
    Park, Jun
    Park, Hyunju
    Choi, Min Sun
    Jang, Hye Won
    Kim, Tae Hyuk
    Kim, Sun Wook
    Chung, Jae Hoon
    CANCERS, 2021, 13 (22)
  • [37] Is lymph node involvement associated with mortality risk in younger patients with papillary thyroid cancer?
    Adam, Mohamed Abdelgadir
    Stang, Michael T.
    Sosa, Julie Ann
    Roman, Sanziana A.
    EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM, 2016, 11 (03) : 233 - +
  • [38] Lymph node ratio in lateral neck is an independent risk factor for recurrence-free survival in papillary thyroid cancer patients with positive lymph nodes
    Luo, Ziyu
    Hei, Hu
    Qin, Jianwu
    Zheng, Chen
    Gong, Wenbo
    ENDOCRINE, 2022, 78 (03) : 484 - 490
  • [39] Lymph node ratio in lateral neck is an independent risk factor for recurrence-free survival in papillary thyroid cancer patients with positive lymph nodes
    Ziyu Luo
    Hu Hei
    Jianwu Qin
    Chen Zheng
    Wenbo Gong
    Endocrine, 2022, 78 : 484 - 490
  • [40] The significance of Delphian lymph node in papillary thyroid cancer
    Tan, Zhuo
    Ge, Ming-Hua
    Zheng, Chuan-Ming
    Wang, Qing-Liang
    Nie, Xi-Lin
    Jiang, Lie-Hao
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2017, 13 (05) : E389 - E393